Literature DB >> 33852095

Sexual Identity, Sexual Behavior and Pre-exposure Prophylaxis in Black Cisgender Sexual Minority Men: The N2 Cohort Study in Chicago.

Liadh Timmins1, John A Schneider2,3, Yen-Tyng Chen2,4, William C Goedel5, Russell Brewer2,3, Denton Callander6, Justin Knox6, Rebecca Eavou2, Hillary Hanson2, Dustin T Duncan6.   

Abstract

This study investigated sexual identity and behavior and their potential associations with PrEP use and attitudes in cisgender Black gay and bisexual men. A total of N = 173 (mean age 25.2) participants from the Neighborhoods and Networks (N2) Study in Chicago were included. Of these, 104 were gay-identified and reported sex with men only (GSMO), 26 were gay-identified and reported sex with men and women (GSMW), 8 were bisexual-identified and reported sex with men only (BSMO), and 35 were bisexual-identified and reported sex with men and women (BSMW). Reporting sex with men and women in the past 6 months, RR = 0.39, 95% CI [0.17, 0.89], identifying as bisexual, RR = 0.52, 95% CI [0.29, 0.92], and the combination of the two, RR = 0.24, 95% CI [0.07, 0.76] were significantly associated with lower rates of current oral PrEP use. Black bisexual-identifying men who reported sex with men and women were significantly more likely to have discontinued oral PrEP, RR = 2.50, 95% CI [1.14, 5.50], than Black gay-identified men who reported sex with men only. Participants who had not used oral PrEP before reported lower levels of interest in long-acting injectable PrEP than those who were currently using oral PrEP, RR = 0.56, 95% CI [0.40, 0.79]. No other significant differences were found. Overlooking the combination of sexual identity and behavior may mischaracterize PrEP rates and miss uniquely vulnerable subgroups. Black gay and bisexual men who had not used oral PrEP may be particularly disinterested in long-acting injectable PrEP.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Long-acting injectable PrEP; Men who have sex with men; Pre-exposure prophylaxis; Sexual identity; Sexual minority men

Mesh:

Year:  2021        PMID: 33852095      PMCID: PMC8419005          DOI: 10.1007/s10461-021-03246-4

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  46 in total

1.  Willingness to use pre-exposure prophylaxis among Black and White men who have sex with men in Atlanta, Georgia.

Authors:  Charlotte-Paige Rolle; Eli S Rosenberg; Nicole Luisi; Jeremy Grey; Travis Sanchez; Carlos Del Rio; John L Peterson; Paula M Frew; Patrick S Sullivan; Colleen F Kelley
Journal:  Int J STD AIDS       Date:  2016-10-20       Impact factor: 1.359

2.  Reaching High-Risk Patients for HIV Preexposure Prophylaxis.

Authors:  James Riddell; Jonathan A Cohn
Journal:  JAMA       Date:  2016-07-12       Impact factor: 56.272

3.  Uptake of HIV Preexposure Prophylaxis Among Commercially Insured Persons-United States, 2010-2014.

Authors:  Hsiu Wu; Maria C B Mendoza; Ya-Lin A Huang; Tameka Hayes; Dawn K Smith; Karen W Hoover
Journal:  Clin Infect Dis       Date:  2016-10-19       Impact factor: 9.079

4.  A Multi-US City Assessment of Awareness and Uptake of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Black Men and Transgender Women Who Have Sex with Men.

Authors:  Lisa A Eaton; Derrick D Matthews; Daniel D Driffin; Leigh Bukowski; Patrick A Wilson; Ron D Stall
Journal:  Prev Sci       Date:  2017-07

5.  Reconsidering Approaches to Estimating Health Disparities Across Multiple Measures of Sexual Orientation.

Authors:  Jessica N Fish; Evan A Krueger
Journal:  LGBT Health       Date:  2020-04-21       Impact factor: 4.151

6.  Lifetime risk of a diagnosis of HIV infection in the United States.

Authors:  Kristen L Hess; Xiaohong Hu; Amy Lansky; Jonathan Mermin; Hildegard Irene Hall
Journal:  Ann Epidemiol       Date:  2017-02-21       Impact factor: 3.797

7.  Prevalence and Correlates of PrEP Awareness and Use Among Black Men Who Have Sex with Men and Women (MSMW) in the United States.

Authors:  M Reuel Friedman; Jordan M Sang; Leigh A Bukowski; Cristian J Chandler; James E Egan; Lisa A Eaton; Derrick D Matthews; Ken Ho; Henry F Raymond; Ron Stall
Journal:  AIDS Behav       Date:  2019-10

8.  Racial/ethnic and HIV risk category disparities in preexposure prophylaxis discontinuation among patients in publicly funded primary care clinics.

Authors:  Hyman M Scott; Matthew Spinelli; Eric Vittinghoff; Alicia Morehead-Gee; Anne Hirozawa; Catherine James; Hali Hammer; Albert Liu; Monica Gandhi; Susan Buchbinder
Journal:  AIDS       Date:  2019-11-15       Impact factor: 4.177

9.  Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012-2017.

Authors:  Patrick S Sullivan; Robertino Mera Giler; Farah Mouhanna; Elizabeth S Pembleton; Jodie L Guest; Jeb Jones; Amanda D Castel; Howa Yeung; Michael Kramer; Scott McCallister; Aaron J Siegler
Journal:  Ann Epidemiol       Date:  2018-06-22       Impact factor: 3.797

10.  Brief Report: PrEP Uptake, Adherence, and Discontinuation Among California YMSM Using Geosocial Networking Applications.

Authors:  Ian W Holloway; Ryan Dougherty; Jennifer Gildner; Sean C Beougher; Craig Pulsipher; Jorge A Montoya; Aaron Plant; Arleen Leibowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.771

View more
  1 in total

1.  Sleep Disturbance is Associated with Missing PrEP Doses Among Young Black Sexual Minority Men in The N2 study.

Authors:  Jade Pagkas-Bather; Dustin T Duncan; Yen-Tyng Chen; John Cursio; Natascha Del Vecchio; Kenneth H Mayer; Justin Knox; Hillary Hanson; Rebecca Eavou; John A Schneider
Journal:  AIDS Behav       Date:  2022-06-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.